The Effect of High-Intensity Short-Duration Exercise Versus Moderate-Intensity High-Volume Exercise on Glucose Control
1 other identifier
interventional
12
1 country
1
Brief Summary
This study will be conducted as a prospective, randomized crossover trial evaluating non-diabetic and pre-diabetic adults ($n=12$) continuously monitored with Dexcom G7 continuous glucose monitors over an 11-day period. Participants will complete two distinct exercise protocols in a randomized sequence: five consecutive days of Zone 2 aerobic exercise and a single session of high-intensity interval training (HIIT). Primary outcome metrics will focus on mean glucose levels and time in range (TIR, defined as $\\le 120\\text{ mg/dL}$) recorded throughout each active exercise block and its associated recovery window. To evaluate the comparative efficacy of the two modalities, paired within-subject differences will be statistically analyzed against pre-specified non-inferiority margins set at $3\\text{ mg/dL}$ for mean glucose, as well as a primary $3$-point and secondary $5$-point margin for time in range.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2026
CompletedStudy Start
First participant enrolled
September 15, 2026
CompletedFirst Posted
Study publicly available on registry
September 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 20, 2026
September 22, 2026
September 1, 2026
1 month
September 2, 2026
September 18, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Mean Glucose Concentration
Average glucose level recorded by continuous glucose monitor (CGM) across the exercise intervention block and its subsequent recovery window.
Measured continuously over each 5-day exercise/recovery block within the 11-day monitoring period.
Time in Range (TIR)
Percentage of time spent with sensor glucose values under 120mg/dL during the active exercise block and its recovery window.
Measured continuously over each 5-day exercise/recovery block within the 11-day monitoring period.
Study Arms (2)
Moderate Intensity Exercise
EXPERIMENTALFive consecutive days of moderate intensity aerobic exercise
High Intensity Exercise
ACTIVE COMPARATOROne session High-Intensity Interval training
Interventions
The Norwegian 4x4: The workout begins with a 5-to-10-minute warm-up, followed by four separate 4-minute high-intensity intervals where you push your body to 85%-95% of your maximum heart rate (roughly an 8 or 9 out of 10 effort level, where you are breathing too heavily to speak full sentences). Each intense "push" is interspersed with a 3-minute active recovery period of low-intensity movement-such as walking or light cycling-to let your heart rate drop back down to roughly 60%-70% of its maximum before starting the next round.
45 minutes of zone 2 training for five consecutive days
Eligibility Criteria
You may qualify if:
- Age 18 years or older Non-diabetic or pre-diabetic status (defined by medical history or standard screening criteria, e.g., HbA1c \< 6.5%) Capable and willing to participate in both Zone 2 aerobic exercise and high-intensity interval training (HIIT) protocols Willing to wear a continuous glucose monitor (Dexcom G7) continuously for the 11-day study duration Able to provide written informed consent
You may not qualify if:
- Diagnosis of Type 1 or Type 2 diabetes Use of glucose-lowering medications, insulin, or other pharmaceuticals that significantly alter glucose metabolism Current skin conditions, allergies, or sensitivities to medical-grade adhesives that prevent continuous glucose monitor placement Musculoskeletal, cardiovascular, or neurological conditions that contraindicate vigorous exercise or high-intensity interval training Pregnant or planning to become pregnant during the study period Concurrent participation in another clinical trial or interventional exercise study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94143, United States
Related Publications (5)
Dent JR, Stocks B, Campelj DG, Philp A. Transient changes to metabolic homeostasis initiate mitochondrial adaptation to endurance exercise. Semin Cell Dev Biol. 2023 Jul 15;143:3-16. doi: 10.1016/j.semcdb.2022.03.022. Epub 2022 Mar 26.
PMID: 35351374BACKGROUNDCartee GD. Mechanisms for greater insulin-stimulated glucose uptake in normal and insulin-resistant skeletal muscle after acute exercise. Am J Physiol Endocrinol Metab. 2015 Dec 15;309(12):E949-59. doi: 10.1152/ajpendo.00416.2015. Epub 2015 Oct 20.
PMID: 26487009BACKGROUNDColberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016 Nov;39(11):2065-2079. doi: 10.2337/dc16-1728. No abstract available.
PMID: 27926890BACKGROUNDTucker WJ, Fegers-Wustrow I, Halle M, Haykowsky MJ, Chung EH, Kovacic JC. Exercise for Primary and Secondary Prevention of Cardiovascular Disease: JACC Focus Seminar 1/4. J Am Coll Cardiol. 2022 Sep 13;80(11):1091-1106. doi: 10.1016/j.jacc.2022.07.004.
PMID: 36075680BACKGROUNDWei J, Shen M, Li S, Xiao Y, Luo D, Ferrari G, Lee DH, Rezende LFM, Gill JMR, Ahmadi MN, Stamatakis E, Chen X. Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases. Eur Heart J. 2026 Mar 29:ehag168. doi: 10.1093/eurheartj/ehag168. Online ahead of print.
PMID: 41905344BACKGROUND
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeanne Noble, MD
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2026
First Posted
September 18, 2026
Study Start
September 15, 2026
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
October 20, 2026
Last Updated
September 22, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share